Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rabab Hachem"'
Autor:
Rabab Hachem, Gaëtan Assemat, Stéphane Balayssac, Nathalie Martins-Froment, Véronique Gilard, Robert Martino, Myriam Malet-Martino
Publikováno v:
Molecules, Vol 25, Iss 2, p 317 (2020)
Red yeast rice dietary supplements (RYR DS) are largely sold in Western countries for their cholesterol-lowering/regulating effect due to monacolins, mainly monacolin K (MK), which is, in fact, lovastatin, the first statin drug on the market. 1H-NMR
Externí odkaz:
https://doaj.org/article/bf0ef69b705541db85215f01c6b3eacc
Autor:
Stéphane Balayssac, Nathalie Martins-Froment, Myriam Malet-Martino, Véronique Gilard, Rabab Hachem, Robert Martino, Gaëtan Assemat
Publikováno v:
Molecules
Molecules, MDPI, 2020, 25 (2), pp.317. ⟨10.3390/molecules25020317⟩
Molecules, Vol 25, Iss 2, p 317 (2020)
Volume 25
Issue 2
Molecules, MDPI, 2020, 25 (2), pp.317. ⟨10.3390/molecules25020317⟩
Molecules, Vol 25, Iss 2, p 317 (2020)
Volume 25
Issue 2
Red yeast rice dietary supplements (RYR DS) are largely sold in Western countries for their cholesterol-lowering/regulating effect due to monacolins, mainly monacolin K (MK), which is, in fact, lovastatin, the first statin drug on the market. 1H-NMR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0540fce215ec6060751c90df32a70b72
https://hal.archives-ouvertes.fr/hal-02889976
https://hal.archives-ouvertes.fr/hal-02889976
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2014, 98, pp.94-99. ⟨10.1016/j.jpba.2014.05.003⟩
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2014, 98, pp.94-99. ⟨10.1016/j.jpba.2014.05.003⟩
The weight-loss drug lorcaserin, a FDA approved anorectic drug, was isolated from the dietary supplement “Lose quickly” claimed to be a pure natural fast slimming diet pill. After its purification by means of preparative liquid chromatography, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f160d0e57f06c5d921c92116ebd0e554
https://doi.org/10.1016/j.jpba.2014.05.003
https://doi.org/10.1016/j.jpba.2014.05.003
Autor:
Véronique Gilard, Gaëtan Assemat, Robert Martino, Stéphane Balayssac, Myriam Malet-Martino, Nathalie Martins, Rabab Hachem
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2016, 124, pp.34-47. ⟨10.1016/j.jpba.2016.02.022⟩
Journal of Pharmaceutical and Biomedical Analysis, 2016, 124, pp.34-47. ⟨10.1016/j.jpba.2016.02.022⟩
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2016, 124, pp.34-47. ⟨10.1016/j.jpba.2016.02.022⟩
Journal of Pharmaceutical and Biomedical Analysis, 2016, 124, pp.34-47. ⟨10.1016/j.jpba.2016.02.022⟩
One hundred and sixty food supplements (FS) marketed for weight loss and mainly purchased on the Internet were analyzed. All the FS were claimed as 100% natural containing only natural compounds, plant extracts and/or vitamins and the presence of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e479b5b8581984328a9a258f6cf615
https://hal.archives-ouvertes.fr/hal-02060638
https://hal.archives-ouvertes.fr/hal-02060638